In TCGA data, genetic changes in PRKCI (gene of PKCiota), including amplification and mutation, occurred in more than 15% of patients with ESCC, ovarian epithelial tumors (OV), non-small cell lung cancer (NSCLC), and cervical squamous cell carcinoma (CSCC). Here, PRKCI is linked to ovarian epithelial tumor.